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Abstract
Background: The association between oxidative stress (OS) 
and metabolic syndrome (MetS) has been reported in adults. 
We analyzed the relation between circulating oxidized low-
density lipoproteins (Ox-LDL) and MetS in pediatric ages 
in order to define whether plasma Ox-LDL levels are corre-
lated to obesity and whether oxidative damage, using serum 
Ox-LDL levels as a proxy, are associated with MetS.
Methods: We enrolled 178 children (11.8 ± 2.6  years). On 
the basis of a body mass index (BMI) threshold, the sub-
jects were classified as: normal weight BMI <75th percen-
tile; overweight BMI 75–97th percentile; obese BMI >97th 
percentile. Patients were classified as having MetS if they 
met three or more of the following criteria for age and sex: 
BMI >97th percentile, triglyceride levels >95th percentile, 
high-density lipoprotein (HDL) cholesterol level <5th 
percentile, systolic blood pressure (SBP) and/or dias-
tolic blood pressure (DBP) >95th percentile and impaired 
glucose tolerance.
Results: Obese children showed increased MetS preva-
lence (p = 0.001) and higher Ox-LDL levels compared 
to normal- and overweight subjects (p < 0.05), with a 
limited relation between Ox-LDL and MetS (p = 0.06). 
Waist-to-height ratio (W/HtR) (p = 0.02), triglycerides (TG) 
(p = 0.001) and LDL-cholesterol (p < 0.001) resulted inde-
pendent predictors of increased plasma Ox-LDL levels.
Conclusions: Oxidative damage was correlated with a 
hypertriglyceridemic waist phenotype and can be a preco-
cious marker of MetS and cardiometabolic risk in obese 
children.
Keywords: children; metabolic syndrome (MetS); obesity; 
oxidative damage; oxidized-low-density lipoproteins 
(Ox-LDL).
Introduction
Metabolic syndrome (MetS) is a common and complex dis-
order combining obesity, dyslipidemia, hypertension and 
insulin resistance. Once considered typical of adulthood, 
MetS is also currently a serious, social and health-related 
problem in pediatric ages [1, 2].
Childhood obesity is an independent predictor for 
the onset of MetS, and its prevalence increases with the 
degree of obesity [3, 4]. A child with obesity is at higher 
risk of developing MetS and, consequently, is at a higher 
risk of cardiovascular incidents later in life, that can only 
partially be explained by its components [5–7].
There is evidence that low-grade inflammation and 
high oxidative stress (OS) are associated with this risk. The 
increased oxidative environment contributes to a chronic 
inflammatory condition in the body and builds primary 
risk factors for the development of several diseases such 
as diabetes and has cardiovascular complications [7, 8]. On 
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the other hand, the increased OS in obesity and metabolic 
disorders causes progression and sustenance of inflam-
matory conditions upregulating redox signaling pathways 
and altering gene expression of inflammatory markers, 
kicking off a vicious circle [9–12].
Oxidized low-density lipoproten(Ox-LDL) cholesterol 
is a LDL oxidative modification product. Ox-LDL is an addi-
tional cardiovascular risk factor and plays an important 
role in atheromatous plaque formation [8]; its levels cor-
relate with the increasing severity of a disease (e.g. stable 
angina vs. unstable angina vs. myocardial infarction). 
Moreover, Ox-LDL is also considered a reliable marker of 
oxidative damage to lipids, by the European Food Safety 
Authority Panel on Dietetic Products, Nutrition and Aller-
gies, when measured with appropriate specificity immu-
noassays [13].
Recent data suggest that increased OS in adipose 
tissue is an early instigator of MetS and that the redox 
state in adipose tissue is potentially a useful therapeutic 
target for the obesity-associated MetS [11, 12]. Data on the 
association between Ox-LDL levels and MetS have been 
reported in adults [11, 12]; however, in pediatric ages data 
are very limited [14].
We analyzed the relation between circulating Ox-LDL 
and MetS in pediatric ages in order to define whether 
plasma Ox-LDL levels are correlated to obesity and 
whether oxidative damage, using serum Ox-LDL levels as 
a proxy, are associated with MetS.
Patients and methods
We enrolled 178 Caucasian children and adolescents aged 
11.8 ± 2.6 years (88 females and 90 males).
On the basis of a body mass index (BMI, calculated as body 
weight in kilograms divided by body height in meters squared) 
threshold, according to age-sex percentiles [15], subjects were clas-
sified as: normal weight BMI <75th percentile (according to ISPED 
classification); overweight BMI 75–97th percentile; obese BMI >97th 
percentile (according to the World Heath Organization [WHO]). This 
classification was preferred because of the highest sensitivity in iden-
tifying obese subjects with clustered cardiometabolic risk factors [16].
Subjects were referred to our institution for auxological evalu-
ation or obesity by their general practitioner or by their primary 
care pediatric consultant, between November 2015 and December 
2016. Exclusion criteria were any known secondary syndromes with 
or without obesity, any ongoing medical therapy and concomitant 
chronic or acute illnesses.
Methods
Auxological parameters evaluation: Physical examination of the 
patients included weight, height, waist circumference (WC),  pubertal 
stage according to Marshall and Tanner [17, 18] and blood pressure 
measurement. BMI and waist-to-height ratio (W/HtR) were also 
 calculated.
Weight was measured with participants not wearing shoes and 
in light clothing, standing upright in the center of the scale platform 
facing the recorder, hands at sides and looking straight ahead.
Standing height was measured using a Harpenden stadiometer 
with a fixed vertical backboard and an adjustable head piece. The 
measurement was taken on the child in an upright position, with-
out shoes, with their heels together and toes apart, hands at sides, 
aligning the head in the Frankfort horizontal plane. The child was 
instructed to stand as tall as possible, taking a deep breath, and hold-
ing this position to capture the result.
Waist circumference was measured to the nearest centimeter 
with a flexible steel tape measure with participants standing, with 
crossed arms, placing the hands on opposite shoulders. After gently 
exhaling, the abdominal waist circumference was measured on the 
horizontal plane between the lowest portion of the rib cage and the 
uppermost lateral border of the right ilium. Visceral adiposity was 
defined for W/HtR >0.5 [19].
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
blood pressures were measured twice using a mercury sphygmoma-
nometer, after the participant sat comfortably for 5  min, with an 
appropriately sized cuff on the right arm, which was slightly flexed 
at heart level. The second BP measurement was used for analysis. 
Elevated SBP or DBP values were defined when exceeding the 95th 
percentile for age and sex [20].
Biochemical parameters evaluation: In all patients, blood meas-
ures included fasting blood levels of glucose, insulin, total choles-
terol, HDL, cholesterol, triglycerides (TG), Ox-LDL.
Insulin resistance was calculated by homeostasis model assess-
ment for insulin resistance (HOMA-IR) [21].
Serum glucose was measured using the hexokinase-G-6-PDH 
method (Abbott Diagnostics, Rome, Italy). Total cholesterol was 
determined by enzymatic method (Abbott Diagnostics) and HDL-
cholesterol by accelerator selective detergent method (Abbott Diag-
nostics). Triglyceride concentration was measured by the glycerol 
phosphatase oxidase method (Abbott Diagnostics).
Serum insulin was determined by a solid-phase, two-site chemi-
luminescent immunometric assay (Siemens Medical Solutions Diag-
nostics, Milan, Italy).
Serum Ox-LDL levels were measured by a commercial 
 enzyme-linked immunosorbent assay (Ox-LDL ELISA, Merco-
dia, Uppsala, Sweden) on a Sunrise® absorbance microplate 
reader (Tecan, Switzerland), according to the manufacturer’s 
 instructions [22].
Briefly, the assay is based on the sandwich technique in which 
two monoclonal antibodies are directed against separate antigenic 
determinants on the oxidized apolipoprotein B molecule. Each sam-
ple must first be diluted in sample buffer to a final dilution of 1/6561. 
The Ox-LDL concentrations were then calculated based on a six-point 
standard curve (range 0–150.9 U/L).
Results were obtained by multiplying Ox-LDL concentrations 
with the dilution factor (e.g. 6.561) and expressed as unit per liter 
(U/L). As regard the performance characteristics of the assay, the 
detection limit was 0.6 U/L while recovery ranged between 85% 
and 107% (mean value 95%). Mean intra- and inter-assay ana-
lytical imprecision was, respectively, 6.3% and 4.7% coefficient of 
variation (CV).
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Abnormalities in lipid fasting levels were considered for TG val-
ues exceeding the 95th percentile and HDL cholesterol values below 
the 5th percentile for age and sex [23]. Impaired insulin sensitivity 
(ISI) was defined with HOMA-IR that exceeded the 97.5th percentile 
for age and sex [24].
MetS definition
MetS was diagnosed according to Weiss using the criteria modified 
from those of the National Cholesterol Education Program’s Adult 
Treatment Panel III (NCEP-ATPIII) and the WHO [25]. Patients were 
classified as having MetS if they met three or more of the follow-
ing criteria for age and sex: BMI >97th percentile, triglyceride levels 
>95th percentile, HDL cholesterol level <5th percentile, SBP and/or 
DBP >95th percentile and impaired glucose tolerance.
In this recent definition by Weiss et al. [25] BMI was chosen 
as a criterion for the MetS because it correlates with visceral lipid 
distribution, blood pressure and dyslipidemia. Although waist 
circumference is a good predictor of visceral adiposity in chil-
dren, it might not detect differences in body proportions related 
to puberty and therefore no normative values exist for children 
and adolescents. As marker of glucometabolic derangement, a 
pathological level of fasting blood glucose (FBG) and/or altera-
tion of ISI were selected because impaired fasting glucose is rare 
in childhood and insulin resistance precedes glucose abnormali-
ties and plays an important role in the pathogenesis of the transi-
tion from normal glucose tolerance to impaired glucose tolerance 
[26]. The euglycemic-hyperinsulinemic clamp is the gold standard 
for measuring insulin resistance, but this study is invasive, time 
consuming and difficult to apply to children. For these reasons, 
we utilized HOMA-IR as surrogate marker of insulin resistance/
sensitivity [3, 25].
Finally, blood pressure and fasting lipid levels were compared 
with population norms adjusted for age and sex.
This study was conducted according to the Good Clinical 
Practice guidelines and was approved by the Human Ethic Com-
mittees of Fondazione IRCCS Policlinico S. Matteo of Pavia (Pro-
tocol number: 20150005231). The informed written consent of 
a parent or legal guardian was required for subjects aged <18, 
and the subjects aged ≥8 were asked to give their written assent. 
Patients’ parents and patients >8 years gave their written consent 
to data publication.  Our Ethics Committee also approved data 
publication.
Statistical analysis
Data quality control and statistical analyses were performed using 
STATA 11 (StataCorp, College Station, TX, USA). Descriptive statistics 
representing means, standard deviations, percentages and ranges 
were computed.
The analysis of variance (ANOVA), Student’s t-test and the 
Kruskal-Wallis (in case of non-normality of the distributions tests) 
were used to verify that patients’ characteristics did not differ sig-
nificantly between the groups, taking into account the effect of sex 
and age, as possible confounders. The χ2-test was used to test the 
statistical significant differences of altered percentage values among 
the groups.
A multiple regression analysis was applied to evaluate the asso-
ciation between serum Ox-LDL levels and auxological/biochemical 
parameters, taking into account the effect of age and sex as possible 
confounders.
Results
Auxological and metabolic parameters
Based on the BMI percentiles threshold, 49 of the 178 
patients (27.5%) were normal weight, 76 (42.7%) were 
overweight and 53 (29.8%) were obese.
Auxological and metabolic parameters of the three 
groups are reported in Table 1. Subjects were well matched 
for age and sex.
Concerning oxidative damage, children with obesity 
showed higher Ox-LDL levels compared to normal weight 
and overweight subjects (p < 0.05). However, serum 
Ox-LDL levels were not significantly correlated with sex, 
age and pubertal status.
Regression analysis showed a significant correla-
tion between Ox-LDL levels, BMI (p = 0.03, r = 0.15), 
WC (p = 0.01, r = 0.18) and W/HtR (p = 0.001, r = 0.22); 
however, multiple regression analysis identified W/
HtR (CI 95% 13.3–151.5, p = 0.02) as the only auxological 
independent factor for increased serum Ox-LDL levels 
(Figure 1).
Concerning routine biochemical parameters, a sig-
nificant correlation (p < 0.001) was noted between Ox-LDL 
and TG (r = 0.44), total cholesterol (r = 0.63) and LDL-cho-
lesterol (r = 0.68). The exploratory multivariable regres-
sion analysis identified TG (CI 95%: 0.04–0.15, p = 0.001) 
and LDL-cholesterol (CI 95%: 0.19–0.54, p < 0.001) as 
biochemical independent predictors of increased plasma 
Ox-LDL levels. In addition, on an average increase of 1 mg/
dL of LDL-cholesterol, Ox-LDL increases by 0.40 U/L, 
while on an average increase of 1  mg/dL of TG, Ox-LDL 
increases by 0.10 U/L.
No correlation between serum Ox-LDL levels and 
blood pressure was detected.
Metabolic syndrome
In our study population, the overall prevalence of MetS 
was 15.2% (n = 27); particularly, MetS was present in 9.2% 
(n = 9) and in 35.2% (n = 18) of subjects with overweight 
and obesity, respectively (p = 0.001). No normal weight 
subjects met the criteria for MetS.
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Auxological and metabolic parameters in patients 
with and without MetS are reported in Table 2. Subjects 
were well matched for age and sex.
Two subjects (1 M/1 F) in Tanner stage I and 17 sub-
jects (10 M/7 F) in Tanner stages II and III had already 
developed MetS.
Concerning oxidative damage, serum Ox-LDL 
levels were higher in subjects with MetS than in those 
without MetS approaching, but not reaching significance 
(p = 0.06).
Discussion
MetS is emerging as a new clinical problem within pedi-
atric practice. In this report, we confirm an increased 
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Figure 1: Multiple regression analysis.
Serum Ox-LDL levels are the dependent variable while the follow-
ing variables are included as independent factors: BMI (kg/m2), WC 
(cm) and W/HtR. Only W/HtR is an independent factor for increased 
Ox-LDL levels (CI 95% 13.3–151.5, p = 0.02).
Table 1: Auxological and biochemical parameters in our study population.
Parameters Normal weight
(n = 49)
Overweight
(n = 76)
Obesity
(n = 53)
Age, years 11.2 ± 2.5 12.2 ± 2.5 11.5 ± 2.3
Gender, M/F 27/22 35/41 28/25
Pubertal stages, M/F
 Tanner I 11 M/2 F 4 M/2 F 7 M/4 F
 Tanner II–III 12 M/14 F 19 M/15 F 16 M/10 F
 Tanner IV–V 4 M/6 F 12 M/24 F 5 M/11 F
WC, cma,b 62.7 ± 7.5 79.2 ± 7.7 92.9 ± 16
[2.0] [73.7] [100]
W/HtRa,b 0.4 ± 0 0.5 ± 0 0.6 ± 0.1
[0] [57.9] [100]
Fasting glucose, mg/dLb 74 ± 7.4 75.7 ± 9 75.6 ± 10.5
[0] [3.9] [18.9]
Insulin, μU/La,b 5.9 ± 3.4 11.8 ± 11.9 15.9 ± 9.6
[0] [13.2] [49.1]
HOMA-IRa,b 1.1 ± 0.7 2.2 ± 2.1 3 ± 2
[0] [10.5] [37.7]
Triglycerides, mg/dLa,b 49.4 ± 17.2 65.1 ± 27 86.5 ± 45
[4.0] [14.5] [20.8]
HDL-cholesterol, mg/dLa,b 56 ± 10.3 50.7 ± 11.3 45.5 ± 9.4
[4.0] [17.1] [39.6]
LDL-cholesterol, mg/dLa 88.9 ± 23.4 93.5 ± 27 102.1 ± 20.2
[0] [2.6] [0]
Total cholesterol, mg/dL 157.6 ± 28.3 158.3 ± 29.6 163.3 ± 25.8
[0] [2.6] [0]
Ox-LDL, U/La 44.4 ± 11.6 50.6 ± 18.9 52.8 ± 15.9
Systolic pressure, mmHga 101.9 ± 9.1 110 ± 12.9 112.9 ± 10.6
[4] [6.6] [3.8]
Diastolic pressure, mmHga 63.6 ± 8.9 67.9 ± 7.3 71.3 ± 8.4
[8.2] [10.5] [22.6]
Data are reported as mean ± standard deviation. In squared brackets are reported the percentages of altered values (under or above the 
relevant percentile curves for age and sex, as described in Patients and methods section). ap-Value <0.05: age and sex adjusted analysis of 
variance (ANOVA). bp-Value <0.05: χ2-test analysis. WC, waist circumference; Ox-LDL, oxidized LDL cholesterol; W/HtR, waist-to-height ratio. 
Subjects were divided on the basis of the threshold BMI [15].
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prevalence of MetS in participants with obesity com-
pared to normal weight children. Children with obesity 
showed higher Ox-LDL levels compared to normal weight 
and overweight subjects, with a limited relation between 
Ox-LDL and MetS. W/HtR, tryglicerides and LDL-choles-
terol were independent predictors of increased plasma 
Ox-LDL levels.
The synergistic effects of the MetS components may 
lead to cardiovascular disease as children with obesity 
become young adults [5–7], and this may be announced 
by an increased OS biomarkers level [7, 8]. OS may play a 
causative role in the development of obesity and co-mor-
bidities [9–12]. The possible contributors to OS in obesity 
include hyperglycemia, elevated lipid levels, chronic low 
grade inflammation with increased circulating cytokines 
produced by visceral adipose depots as well as myokines 
production by skeletal muscles, in those with low physical 
activity level and higher weigh to carry, endothelial dys-
function, unhealthy diets [7–12].
Evidence has demonstrated that OS levels are ele-
vated in adults with obesity [12], but pediatric data in this 
area are limited. In our sample, Ox-LDL level was meas-
ured as a marker of oxidative damage and it was found to 
be elevated in children with obesity, particularly in those 
with visceral adiposity. Each element of the MetS worsens 
as waist circumference increases, independently of age, 
sex and pubertal status. Recent studies performed in ado-
lescents with obesity showed that abdominal fat, rather 
than BMI, may be the main cause of metabolic impact [19, 
27]. This adverse metabolic phenotype is associated to OS, 
severe insulin resistance and alterations in glucose and 
lipid metabolism [25]. The correlation between Ox-LDL 
levels and W/HtR confirm these data and suggest that 
Ox-LDL high values may reflect and predict MetS develop-
ment in children too.
In adults, Ox-LDL is strongly associated whit MetS 
and its components independently of central obesity and 
insulin resistance and could be useful as early predic-
tive marker of cardiometabolic abnormalities [12]. In our 
sample Ox-LDL levels were higher in subjects with MetS, 
despite the difference in children with and without MetS 
did not reach the usually accepted level of clinical signifi-
cance. In pediatric ages MetS components were rarely all 
present in early stage and this may have influenced the 
limited level of clinical significance; moreover higher 
Ox-LDL values in patients with MetS as well as the asso-
ciation between Ox-LDL, tryglicerides and W/HtR, claim 
that increased oxidative damage and inflammation might 
be involved in the development of the MetS.
The association between Ox-LDL and TG, the strong-
est found among the MetS components, may be partly due 
to their common participation in lipid pathway, beyond 
TG participation in the MetS. Hypertriglyceridemia is 
associated with higher levels of small dense LDL, which 
are particularly prone to oxidation and have been proven 
more atherogenic than larger LDL particles. Moreover, 
the hypothesis that tryglicerides may be an earlier dis-
metabolic marker is not excluded [28]. Lemieux et al. [29] 
demonstrated that the combination of only two MetS com-
ponents, increased TG levels and WC, defined as hyper-
triglyceridemic waist phenotype, were able to predict 
cardiovascular risk in adult men. Despite high tryglic-
erides levels being a modifiable cardiovascular risk factor, 
it is undeniable that they contribute to oxidative damage.
Table 2: Auxological and biochemical parameters in our study 
population.
Parameters Without metabolic 
syndrome
(n = 151)
With metabolic 
syndrome
(n = 27)
Age, years 11.6 (2.4) 12.4 (2.6)
Gender, M/F 74/77 16/11
Waist circumference, cma,b 76.2 (14.1) 93.2 (16.8)
[57.6] [85.2]
Waist-to-height ratioa,b 0.5 (0.1) 0.6 (0.1)
[49.0] [85.2]
Pubertal stages
 Tanner I 21 M/7 F 1 M/1 F
 Tanner II–III 37 M/32 F 10 M/7 F
 Tanner IV–V 16 M/38 F 5 M/3 F
Fasting glucose, mg/dLa,b 74.4 (7.7) 79.6 (14)
[0] [14.8]
Insulin, μU/La,b 9.5 (5.4) 23 (19.7)
[12.6] [85.2]
HOMA-IRa,b 1.8 (1) 4.5 (3.6)
[7.2] [66.7]
Triglycerides, mg/dLa,b 61.5 (25.1) 102.3 (54.5)
[4.0] [44.4]
HDL-cholesterol, mg/dLa,b 52.3 (10.5) 39.9 (8.2)
[11.0] [74.1]
LDL-cholesterol, mg/dL 95 (24.8) 95.7 (23.7)
[1.3] [0]
Total cholesterol, mg/dL 160.7 (27.7) 154.7 (29.9)
[1.3] [0]
Ox-LDL, U/L 48.8 (15.9) 54.1 (19.4)
Systolic pressure, mmHga,b 106.7 (10.6) 120.9 (13.1)
[2.0] [22.3]
Diastolic pressure, mmHga,b 66.6 (7.7) 74.6 (9.8)
[7.3] [48.1]
Data are reported as mean and (standard deviation). In squared 
brackets are reported the percentages of altered values (under or 
above the relevant percentile curves for age and sex, as described 
in Materials and Methods section). ap-Value <0.05: age and sex 
adjusted analysis of variance (ANOVA). bp-Value <0.05: χ2-test analy-
sis. WC, waist circumference; Ox-LDL, oxidized LDL cholesterol.
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The free fatty acids available in situations leading to 
MetS, induce insulin resistance, inhibiting insulin-medi-
ated glucose uptake, that is associated with other meta-
bolic variables [25].
In addition to the impact of lipid profiles, OS has also 
been linked with important cardiovascular risk factors [8–
12, 30]. Vascular dysfunction is documented as an impor-
tant process in driving the pathologies associated with 
obesity and hypertension. Human and animal models of 
obesity have demonstrated altered vascular contractil-
ity and decreased dilator function promoting hyperten-
sion. The mechanisms causing this vascular dysfunction 
involve the combinatorial effects of OS and inflamma-
tory signaling, widely recognized as major players in the 
pathogenesis of cardiovascular diseases and overt hyper-
tension [31]. In our children with obesity, no correlation 
between serum Ox-LDL levels and blood pressure was 
detected, providing minimal evidence of such association 
with early, pre-clinical abnormalities of blood pressure vs. 
overt hypertension.
We recognize that there are some study limitations 
starting from the sample, relatively small, which did not 
allows to us to build cut-off values or reference intervals 
for Ox-LDL levels in our study population. Therefore, 
expanding sampling is mandatory.
Additionally, we particularly want to underline that 
we did not evaluate OS status but oxidative damage. In 
fact, as previously reported in the literature [32], under 
normal physiological conditions, reactive oxygen species 
(ROS) can be eliminated or inactivated in vivo by differ-
ent antioxidant systems. However, OS occurs either when 
there is an increase of ROS or a decrease in the antioxi-
dant systems or damage induced by OS, such as Ox-LDL 
production [33], as a consequence of oxidants-antioxi-
dant imbalance [32]. Based on these considerations, the 
authors think that is more correct to refert to an oxidative 
damage rather than OS, underlying that further studies, in 
order to evaluate the antioxidant systems are mandatory.
However, given the few data so far reported in pediat-
ric ages, we believe that the observed increased levels of 
Ox-LDL, approaching conventional levels of significance, 
in subjects with MetS in our population, offer a good start-
ing point for further investigation on oxidative damage 
and the development of chronic degenerative diseases in 
the young ones. Changes in oxidative damage biomarkers, 
such as Ox-LDL, in pediatric ages, could have a potential 
clinical meaning and may be an early marker of long-term 
chronic diseases, like MetS, and cardiometabolic risk in 
those with an adverse metabolic phenotype.
Targeting actions toward OS biomarkers, linked to 
insulin-related metabolic processes, could lead to more 
homogeneous evidence to tackle obesity and overweight 
in children, confirming the need of a prospective change 
of the obesity concept already suggested by other authors 
[34] for efficient global action.
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